IMG-20260715-WA0015.jpg

IMG-20260715-WA0016.jpg

Give answers of rhis

Reading File

Finding Sources

Here are the complete answers with explanations:

Answers - Biochemistry of Glucose Metabolism

1.1 A 4-month-old infant with severe fasting hypoglycemia, hepatomegaly, lactic acidosis, elevated serum uric acid and triglycerides - enzyme deficiency?

Answer: (D) Glucose-6-phosphatase

This is a classic presentation of Von Gierke Disease (GSD Type I) - deficiency of glucose-6-phosphatase. The enzyme is needed to release free glucose from glucose-6-phosphate in the liver. Without it:

Glycogen and fat accumulate in the liver (hepatomegaly)
Fasting hypoglycemia (glucose cannot be exported)
Lactic acidosis (pyruvate/lactate build up)
Hyperuricemia (elevated uric acid) and hypertriglyceridemia

As confirmed by Lippincott Biochemistry 8e: "Type I - Von Gierke disease: Glucose-6-phosphatase deficiency -> Lactic acidosis, hypoglycemia, hyperuricemia, impaired growth."

1.2 Gluconeogenesis is decreased by:

Answer: (D) Insulin

Glucagon (A), Epinephrine (B), and Glucocorticoids (C) all stimulate gluconeogenesis. Insulin is the only hormone that inhibits gluconeogenesis. As noted in Basic Medical Biochemistry 6e: "Glucagon and epinephrine promote glucose release from the liver, activating glycogenolysis and gluconeogenesis. Cortisol will stimulate both glycogen synthesis and gluconeogenesis." Insulin opposes all these effects.

1.3 Lactate formed in muscles can be utilized through:

Answer: (C) Cori's cycle

In the Cori cycle, lactate produced by anaerobic glycolysis in muscle is transported to the liver via the blood, where it is converted back to glucose (via gluconeogenesis), which is then returned to the muscle. From Lippincott 8e: "In the Cori cycle, this lactate is taken up by the liver and oxidized to pyruvate that is converted to glucose, which is released back into the circulation."

1.4 Glucose-6-phosphatase is NOT present in:

Answer: (D) Muscles and adipose tissue

Glucose-6-phosphatase is present in liver and kidneys (renal cortex) only. It is absent from muscle and adipose tissue. From Harper's Illustrated Biochemistry 32e: "It is present in liver and kidney (renal cortex), but absent from muscle, which therefore cannot export glucose derived from glycogen into the bloodstream."

1.5 Pyruvate carboxylase is regulated by:

Answer: (D) All of these

Pyruvate carboxylase is regulated by multiple mechanisms:

Allosteric regulation: Acetyl-CoA is a key allosteric activator; it is inactive without acetyl-CoA
Induction: Its synthesis is induced by glucocorticoids and glucagon (long-term regulation)
Repression: Insulin represses its gene expression

From Lippincott 8e: "Acetyl CoA from β-oxidation is the allosteric activator of pyruvate carboxylase, a gluconeogenic enzyme." All three regulatory mechanisms apply, making (D) All of these correct.

Make pdf of this or flash card

Asking for Preferences

Reading File

Running Command

mkdir -p /tmp/workspace/biochem-pdf && ls /tmp/workspace/

Writing File

~/biochem-pdf/make_pdf.py

from reportlab.lib.pagesizes import A4
from reportlab.lib.styles import getSampleStyleSheet, ParagraphStyle
from reportlab.lib.units import cm
from reportlab.lib import colors
from reportlab.platypus import SimpleDocTemplate, Paragraph, Spacer, HRFlowable, Table, TableStyle
from reportlab.lib.enums import TA_LEFT, TA_CENTER, TA_JUSTIFY

OUTPUT = "/tmp/workspace/biochem-pdf/Glucose_Metabolism_QA.pdf"

doc = SimpleDocTemplate(
    OUTPUT,
    pagesize=A4,
    rightMargin=2*cm,
    leftMargin=2*cm,
    topMargin=2*cm,
    bottomMargin=2*cm,
)

styles = getSampleStyleSheet()

# Custom styles
title_style = ParagraphStyle(
    'CustomTitle',
    parent=styles['Title'],
    fontSize=20,
    textColor=colors.HexColor('#1a3c6e'),
    spaceAfter=6,
    spaceBefore=0,
    alignment=TA_CENTER,
)
subtitle_style = ParagraphStyle(
    'Subtitle',
    parent=styles['Normal'],
    fontSize=11,
    textColor=colors.HexColor('#555555'),
    spaceAfter=16,
    alignment=TA_CENTER,
)
q_style = ParagraphStyle(
    'Question',
    parent=styles['Normal'],
    fontSize=11,
    leading=15,
    textColor=colors.HexColor('#1a3c6e'),
    fontName='Helvetica-Bold',
    spaceBefore=14,
    spaceAfter=6,
)
options_style = ParagraphStyle(
    'Options',
    parent=styles['Normal'],
    fontSize=10,
    leading=14,
    textColor=colors.HexColor('#333333'),
    leftIndent=12,
    spaceAfter=4,
)
answer_label_style = ParagraphStyle(
    'AnswerLabel',
    parent=styles['Normal'],
    fontSize=10.5,
    fontName='Helvetica-Bold',
    textColor=colors.HexColor('#ffffff'),
    spaceBefore=6,
    spaceAfter=3,
)
answer_text_style = ParagraphStyle(
    'AnswerText',
    parent=styles['Normal'],
    fontSize=10,
    leading=14,
    textColor=colors.HexColor('#1a1a1a'),
    alignment=TA_JUSTIFY,
    spaceAfter=4,
)
source_style = ParagraphStyle(
    'Source',
    parent=styles['Normal'],
    fontSize=8.5,
    textColor=colors.HexColor('#777777'),
    fontName='Helvetica-Oblique',
    spaceAfter=4,
)

# ── Data ──────────────────────────────────────────────────────────────────────
qa_data = [
    {
        "num": "1.1",
        "question": (
            "A 4-month-old infant presents with severe fasting hypoglycemia, "
            "hepatomegaly, and lactic acidosis. Laboratory evaluation shows elevated "
            "serum uric acid and triglycerides. This patient most likely has a deficiency "
            "in which of the following enzymes?"
        ),
        "options": [
            ("A", "Hexokinase"),
            ("B", "Phosphofructokinase"),
            ("C", "Pyruvate carboxylase"),
            ("D", "Glucose-6-phosphatase"),
        ],
        "answer": "D",
        "correct": "Glucose-6-phosphatase",
        "explanation": (
            "This is a classic presentation of Von Gierke Disease (GSD Type I) — deficiency of "
            "glucose-6-phosphatase. Without this enzyme, the liver cannot release free glucose "
            "from glucose-6-phosphate, leading to: hepatomegaly (glycogen/fat accumulation), "
            "fasting hypoglycemia (no glucose export), lactic acidosis (pyruvate/lactate build-up), "
            "hyperuricemia, and hypertriglyceridemia."
        ),
        "source": "Lippincott Biochemistry 8e — Table 11.1; Yamada's Gastroenterology 7e",
    },
    {
        "num": "1.2",
        "question": "Gluconeogenesis is decreased by:",
        "options": [
            ("A", "Glucagon"),
            ("B", "Epinephrine"),
            ("C", "Glucocorticoids"),
            ("D", "Insulin"),
        ],
        "answer": "D",
        "correct": "Insulin",
        "explanation": (
            "Glucagon, Epinephrine, and Glucocorticoids all stimulate gluconeogenesis — "
            "they are counter-regulatory hormones that raise blood glucose. "
            "Insulin is the only hormone here that inhibits gluconeogenesis by suppressing "
            "key gluconeogenic enzymes (PEPCK, fructose-1,6-bisphosphatase, glucose-6-phosphatase)."
        ),
        "source": "Basic Medical Biochemistry 6e — Regulation of Fuel Metabolism",
    },
    {
        "num": "1.3",
        "question": "Lactate formed in muscles can be utilized through:",
        "options": [
            ("A", "Rapoport-Luebeling cycle"),
            ("B", "Glucose-alanine cycle"),
            ("C", "Cori's cycle"),
            ("D", "Citric acid cycle"),
        ],
        "answer": "C",
        "correct": "Cori's cycle",
        "explanation": (
            "In the Cori cycle, lactate produced by anaerobic glycolysis in muscle is transported "
            "via the blood to the liver, where it is converted back to glucose "
            "(pyruvate → gluconeogenesis), which is then returned to muscle. "
            "The Rapoport-Luebeling cycle involves 2,3-BPG in RBCs; the glucose-alanine cycle "
            "carries nitrogen, not lactate primarily."
        ),
        "source": "Lippincott Biochemistry 8e — Section B, Lactate (Cori Cycle)",
    },
    {
        "num": "1.4",
        "question": "Glucose-6-phosphatase is NOT present in:",
        "options": [
            ("A", "Liver and kidneys"),
            ("B", "Kidneys and muscles"),
            ("C", "Kidneys and adipose tissue"),
            ("D", "Muscles and adipose tissue"),
        ],
        "answer": "D",
        "correct": "Muscles and adipose tissue",
        "explanation": (
            "Glucose-6-phosphatase is present in the liver and renal cortex (kidneys) — "
            "organs that export glucose to the blood. It is ABSENT in muscle and adipose tissue. "
            "This is why muscle cannot export free glucose derived from glycogen into the bloodstream."
        ),
        "source": "Harper's Illustrated Biochemistry 32e — Glucose-6-Phosphate & Glucose",
    },
    {
        "num": "1.5",
        "question": "Pyruvate carboxylase is regulated by:",
        "options": [
            ("A", "Induction"),
            ("B", "Repression"),
            ("C", "Allosteric regulation"),
            ("D", "All of these"),
        ],
        "answer": "D",
        "correct": "All of these",
        "explanation": (
            "Pyruvate carboxylase is regulated by all three mechanisms:\n"
            "• Allosteric regulation: Acetyl-CoA is the obligate allosteric activator; "
            "the enzyme is virtually inactive without it.\n"
            "• Induction: Glucocorticoids and glucagon induce its synthesis during fasting/stress.\n"
            "• Repression: Insulin represses gene expression, reducing enzyme levels in the fed state."
        ),
        "source": "Lippincott Biochemistry 8e; Basic Medical Biochemistry 6e — Pyruvate carboxylase regulation",
    },
]

# ── Build story ────────────────────────────────────────────────────────────────
story = []

# Title block
story.append(Paragraph("Biochemistry of Glucose Metabolism", title_style))
story.append(Paragraph("MCQ Answer Sheet — Cases 1.1 to 1.5", subtitle_style))
story.append(HRFlowable(width="100%", thickness=2, color=colors.HexColor('#1a3c6e'), spaceAfter=14))

for i, qa in enumerate(qa_data):
    # Question number + text
    story.append(Paragraph(f"Q{qa['num']}.  {qa['question']}", q_style))

    # Options
    for letter, text in qa["options"]:
        marker = "✓ " if letter == qa["answer"] else "      "
        opt_color = colors.HexColor('#1a7a3e') if letter == qa["answer"] else colors.HexColor('#333333')
        opt_style = ParagraphStyle(
            f'opt_{letter}',
            parent=options_style,
            textColor=opt_color,
            fontName='Helvetica-Bold' if letter == qa["answer"] else 'Helvetica',
        )
        story.append(Paragraph(f"({letter})  {text}{'  ✓' if letter == qa['answer'] else ''}", opt_style))

    # Answer box (table for background colour)
    answer_content = [
        [Paragraph(f"ANSWER: ({qa['answer']}) {qa['correct']}", ParagraphStyle(
            'ans_head', fontName='Helvetica-Bold', fontSize=11,
            textColor=colors.white, leading=14,
        ))],
        [Paragraph(qa["explanation"], ParagraphStyle(
            'ans_body', fontSize=9.5, leading=14,
            textColor=colors.HexColor('#1a1a1a'), alignment=TA_JUSTIFY,
        ))],
        [Paragraph(f"Source: {qa['source']}", ParagraphStyle(
            'ans_src', fontSize=8, fontName='Helvetica-Oblique',
            textColor=colors.HexColor('#555555'),
        ))],
    ]

    tbl = Table(answer_content, colWidths=[16.8*cm])
    tbl.setStyle(TableStyle([
        ('BACKGROUND', (0, 0), (0, 0), colors.HexColor('#1a3c6e')),
        ('BACKGROUND', (0, 1), (0, 1), colors.HexColor('#eaf2fb')),
        ('BACKGROUND', (0, 2), (0, 2), colors.HexColor('#f5f5f5')),
        ('BOX', (0, 0), (-1, -1), 1, colors.HexColor('#1a3c6e')),
        ('INNERGRID', (0, 0), (-1, -1), 0.5, colors.HexColor('#c0c0c0')),
        ('TOPPADDING', (0, 0), (-1, -1), 6),
        ('BOTTOMPADDING', (0, 0), (-1, -1), 6),
        ('LEFTPADDING', (0, 0), (-1, -1), 10),
        ('RIGHTPADDING', (0, 0), (-1, -1), 10),
        ('VALIGN', (0, 0), (-1, -1), 'TOP'),
    ]))

    story.append(Spacer(1, 6))
    story.append(tbl)

    if i < len(qa_data) - 1:
        story.append(HRFlowable(width="100%", thickness=0.5, color=colors.HexColor('#cccccc'), spaceAfter=4, spaceBefore=10))

# Footer note
story.append(Spacer(1, 20))
story.append(HRFlowable(width="100%", thickness=1, color=colors.HexColor('#1a3c6e'), spaceBefore=4))
story.append(Paragraph(
    "References: Lippincott Illustrated Reviews Biochemistry 8e | Harper's Illustrated Biochemistry 32e | "
    "Basic Medical Biochemistry 6e | Yamada's Textbook of Gastroenterology 7e",
    ParagraphStyle('footer', fontSize=8, textColor=colors.HexColor('#777777'), fontName='Helvetica-Oblique',
                   spaceBefore=6, alignment=TA_CENTER)
))

doc.build(story)
print(f"PDF created: {OUTPUT}")

Running Command

python /tmp/workspace/biochem-pdf/make_pdf.py

Your PDF is ready! Here's what's included:

All 5 questions (Q1.1 - Q1.5) with full options
Correct answer highlighted in green with a tick mark
Colour-coded answer box (blue header, light blue explanation, grey source)
Detailed explanation for each answer
Textbook references at the bottom

Glucose Metabolism QA

PDF Document · PDF

Give answers of this

+4 more

Give answers of this

Finding Sources

Here are all the answers:

Answers - Glycogen & Pentose Phosphate Pathway (Bio_Glycogen_2.2)

5.2. What is the first reaction of the pentose phosphate pathway?

Answer: (a) Oxidation of glucose-6-phosphate to 6-phosphoglucono-δ-lactone

The oxidative phase of the pentose phosphate pathway begins with glucose-6-phosphate being oxidized by glucose-6-phosphate dehydrogenase (G6PD) - the rate-limiting enzyme - to 6-phosphoglucono-δ-lactone, with simultaneous reduction of NADP⁺ to NADPH. This is the committed, first step. Option (b) is the second reaction (lactonase step). Options (c) and (d) are reversed and incorrect.

Source: Lippincott Biochemistry 8e — Figure 13.2; Harper's Biochemistry 32e

5.3. Which statement is correct about the oxidative pentose phosphate pathway?

Answer: (c) The pathway supplies ribose-5-phosphate and NADPH in the quantities the cell requires

(a) Wrong - it generates NADPH, not NADH
(b) Wrong - it reduces NADP⁺ to NADPH (not the reverse)
(c) Correct - the pathway's two major products are NADPH (for reductive biosynthesis/antioxidant defense) and ribose-5-phosphate (for nucleotide synthesis), and the non-oxidative phase allows flexible production of each in the ratio needed
(d) Wrong - the rate-limiting enzyme is glucose-6-phosphate dehydrogenase, not glucose-6-phosphatase

Source: Basic Medical Biochemistry 6e — The Pentose Phosphate Pathway; Medical Physiology (Boulpaep & Boron)

5.4. Importance of branching in glycogen structure?

Answer: (D) Occurs after every 4-6 glucose residues

Branching in glycogen is carried out by the branching enzyme (amylo-4,6-transferase) - NOT glycogen synthase (eliminates A). A branch point is created approximately every 4-6 glucose residues. Branching:

Increases solubility (eliminates B - it INCREASES, not decreases)
Increases (not decreases) the number of non-reducing ends, allowing faster synthesis AND degradation simultaneously (eliminates C - the rate is increased, not just described by C)
Increases compaction (eliminates E)

Option D correctly states that branching occurs after every 4-6 glucose residues, which is the structural fact defining the branching enzyme's action.

Source: Basic Medical Biochemistry 6e — Glycogen Synthesis; Lippincott 8e — Q11.2 answer

5.5. Which enzyme acts in the pentose phosphate pathway?

Answer: (d) 6-phosphogluconate dehydrogenase

(a) Aldolase - glycolysis enzyme
(b) Glycogen phosphorylase - glycogenolysis enzyme
(c) Pyruvate kinase - glycolysis enzyme
(d) 6-phosphogluconate dehydrogenase - this is the third reaction of the pentose phosphate pathway (oxidative phase), catalyzing oxidative decarboxylation of 6-phosphogluconate to ribulose-5-phosphate + CO₂, generating a second NADPH

Source: Harper's Biochemistry 32e — The Oxidative Phase; Lippincott 8e — Figure 13.2

5.6. Under which condition do you expect glycogen synthase to be active?

Answer: (B) High carbohydrate feeding

Glycogen synthase is activated by dephosphorylation, which is triggered by insulin (elevated after a high-carbohydrate meal). When blood glucose and insulin are high, protein phosphatases dephosphorylate glycogen synthase from its inactive (phosphorylated) form to its active form.

(A) Excess glycogen stores - would actually inhibit further synthesis via feedback
(C) High-fat feeding - does not raise insulin enough to activate glycogen synthase
(D) Starvation - glucagon is high, insulin is low; glycogen synthase is inactive (phosphorylated)
(E) Uncontrolled diabetes - insulin is absent/deficient; glycogen synthase remains inactive

Source: Basic Medical Biochemistry 6e — Glycogen Synthase regulation; Lippincott 8e

Pentose pyruvate pathways

Finding Sources

Reading File

Loading Image

Reading File

Here is everything you need - the pending MCQ answers first, then a full notes on the Pentose Phosphate Pathway.

Pending MCQ Answers

5.2. What is the first reaction of the pentose phosphate pathway?

Answer: (a) Oxidation of glucose 6-phosphate to 6-phosphoglucono-δ-lactone

This is catalyzed by glucose 6-phosphate dehydrogenase (G6PD) - the rate-limiting enzyme of the pathway. It reduces NADP⁺ to NADPH. This is an irreversible oxidative reaction. (Lippincott 8e, Fig 13.2)

5.3. Which statement is correct about the oxidative pentose phosphate pathway?

Answer: (c) The pathway supplies ribose 5-phosphate and NADPH in the quantities the cell requires

(a) Wrong - it generates NADPH, not NADH
(b) Wrong - it reduces NADP⁺ to NADPH (not the reverse)
(d) Wrong - the rate-limiting enzyme is glucose 6-phosphate dehydrogenase, not glucose 6-phosphatase

(Lippincott 8e; Basic Medical Biochemistry 6e)

5.4. Importance of branching in glycogen structure?

Answer: (C) Increases the rate of glycogen synthesis and degradation — but more precisely, the best answer is (D) Occurs after every 4-6 glucose residues

Actually reading all options carefully:

(A) Wrong - branching is done by branching enzyme (amylo-1,4→1,6-transglycosylase), NOT glycogen synthase
(B) Wrong - branching increases solubility (not decreases)
(C) Partially correct - branches do increase the number of non-reducing ends, speeding synthesis and degradation
(D) Correct - branching enzyme adds a branch after every 4-6 glucose residues
(E) Wrong - branching increases compaction

Answer: (D) Occurs after every 4-6 glucose residues

From Lippincott 8e: "Branching enzyme (4:6 transferase) deficiency results in glycogen with fewer branches and decreased solubility." Basic Medical Biochemistry 6e: "Branching of glycogen serves two major roles: increased sites for synthesis and degradation and enhancing the solubility of the molecule."

5.5. Which enzyme acts in the pentose phosphate pathway?

Answer: (d) 6-phosphogluconate dehydrogenase

Aldolase - glycolysis
Glycogen phosphorylase - glycogenolysis
Pyruvate kinase - glycolysis
6-phosphogluconate dehydrogenase - step 3 of the PPP oxidative phase (converts 6-phosphogluconate → ribulose 5-phosphate + CO₂ + NADPH)

(Lippincott 8e, Fig 13.2; Harper's 32e)

5.6. In which condition is glycogen synthase active?

Answer: (B) High carbohydrate feeding

(A) Excess glycogen stores - this inhibits synthase (product inhibition)
(B) High carbohydrate feeding - insulin rises → protein phosphatases activate → glycogen synthase is dephosphorylated = ACTIVE ✓
(C) High-fat feeding - no insulin stimulus for glycogen synthesis
(D) Starvation - glucagon/epinephrine dominate → synthase is phosphorylated = INACTIVE
(E) Uncontrolled diabetes - insulin absent → synthase remains inactive

From Basic Medical Biochemistry 6e: "Glycogen synthase is activated by dephosphorylation, which occurs when insulin is elevated and glucagon is decreased."

Pentose Phosphate Pathway (HMP Shunt) - Full Notes

Overview

Also called: Hexose Monophosphate (HMP) Shunt or Phosphogluconate pathway
Location: Cytosol
Does NOT produce ATP
Two major products: NADPH and Ribose 5-phosphate
Substrate: Glucose 6-phosphate

Phase 1 - Oxidative Phase (IRREVERSIBLE)

Three steps generating 2 NADPH per glucose 6-phosphate:

Step	Enzyme	Reaction	Product
1	G6PD (rate-limiting)	Glucose 6-P → 6-phosphoglucono-δ-lactone	NADPH
2	6-phosphogluconolactone hydrolase	Lactone → 6-phosphogluconate	-
3	6-phosphogluconate dehydrogenase	6-PG → Ribulose 5-P + CO₂	NADPH

Net: Glucose 6-P → Ribulose 5-P + 2 NADPH + CO₂

Phase 2 - Nonoxidative Phase (REVERSIBLE)

Ribulose 5-P is interconverted by isomerases/epimerases to Ribose 5-P or Xylulose 5-P
Transketolase (requires TPP/Thiamine) transfers 2-carbon units
Transaldolase transfers 3-carbon units
End products feed into glycolysis (fructose 6-P, glyceraldehyde 3-P)

Here is the complete pathway diagram from Lippincott:

Pentose Phosphate Pathway diagram showing oxidative and nonoxidative phases

Active Tissues (where PPP is most active)

Liver - fatty acid synthesis
Adipose tissue - fatty acid synthesis
Adrenal cortex, gonads - steroid hormone synthesis
Lactating mammary gland - fatty acid synthesis
Red blood cells - glutathione reduction (anti-oxidant defense)
Low in: skeletal muscle, heart

NADPH Uses

Fatty acid synthesis (liver, mammary gland)
Steroid/cholesterol synthesis (adrenal, gonads)
Glutathione reduction - protects RBCs from oxidative damage
Cytochrome P450 reactions (drug detoxification)
Respiratory burst in phagocytes (NADPH oxidase → superoxide)

Regulation

G6PD is the key regulated enzyme
Inhibited by: NADPH (product inhibition)
Activated by: high NADP⁺/NADPH ratio
Induced by: Insulin (in absorptive state)

Clinical Importance - G6PD Deficiency

X-linked recessive (affects mostly males)
Most common enzyme deficiency worldwide
RBCs are most vulnerable - they have no mitochondria, so PPP is the only NADPH source
Without NADPH → glutathione cannot be reduced → oxidative damage → Heinz bodies → hemolytic anemia
Triggered by: primaquine, dapsone, fava beans, infections, nitrofurantoin
Also confers protection against malaria (heterozygote advantage)

Summary Table - Pathway Uses Based on Cell Needs

Cell Need	Pathway Used
NADPH only	Oxidative phase → ribulose 5-P recycled back to glucose 6-P via nonoxidative reactions
Ribose 5-P only	Nonoxidative reactions from fructose 6-P and G3P
Both NADPH + Ribose 5-P	Oxidative phase; ribose 5-P retained
NADPH + pyruvate	Both phases used; products enter glycolysis

(Sources: Lippincott Biochemistry 8e, Ch 13; Basic Medical Biochemistry 6e; Harper's Illustrated Biochemistry 32e)

Pentose pyruvate pathways

Finding Sources

Reading File

Loading Image

Finding Sources

Here are complete, exam-ready notes on both pathways.

PENTOSE PHOSPHATE PATHWAY (HMP Shunt)

Overview

Full name: Hexose Monophosphate (HMP) Shunt / Phosphogluconate pathway
Location: Cytosol
Substrate: Glucose 6-phosphate
Does NOT produce ATP
Two key products: NADPH + Ribose 5-phosphate

Phase 1 - OXIDATIVE Phase (Irreversible)

Oxidative phase of pentose phosphate pathway showing step-by-step reactions from Glucose 6-phosphate to Ribulose 5-phosphate

Step	Enzyme	Reaction	Products
1	Glucose 6-phosphate dehydrogenase (G6PD) - rate-limiting	Glucose 6-P → 6-phosphoglucono-δ-lactone	1st NADPH
2	6-Phosphogluconolactone hydrolase	Lactone → 6-phosphogluconate	-
3	6-Phosphogluconate dehydrogenase	6-PG → Ribulose 5-P + CO₂	2nd NADPH

Net per glucose 6-P: → Ribulose 5-P + 2 NADPH + CO₂

Phase 2 - NON-OXIDATIVE Phase (Reversible)

Complete pentose phosphate pathway diagram showing both oxidative and nonoxidative phases with all intermediates and enzymes

Ribulose 5-P is converted by isomerases → Ribose 5-P (for nucleotides) or Xylulose 5-P
Transketolase (requires Thiamine/TPP): transfers 2-carbon units
Transaldolase: transfers 3-carbon units
Final products: Fructose 6-P and Glyceraldehyde 3-P → enter glycolysis

Active Tissues (High PPP activity)

Tissue	Purpose
Liver, Adipose, Mammary gland	Fatty acid synthesis (needs NADPH)
Adrenal cortex, Gonads, Placenta	Steroid hormone synthesis
Red blood cells	Glutathione reduction (anti-oxidant)
Phagocytes (neutrophils)	Respiratory burst (NADPH oxidase)
Low in: Skeletal muscle	-

NADPH - Functions

Fatty acid synthesis
Steroid/cholesterol synthesis
Glutathione reduction (GSH regeneration in RBCs)
Cytochrome P450 drug detoxification
NADPH oxidase - superoxide for killing bacteria
Nitric oxide synthesis

Regulation of G6PD

Inhibited by: NADPH (product inhibition - when NADPH is high, pathway slows)
Induced by: Insulin (in fed/absorptive state)
Active when: NADP⁺/NADPH ratio is high (cell needs reducing power)

Clinical: G6PD Deficiency

X-linked recessive - affects mostly males
Most common enzyme deficiency worldwide
RBCs are most vulnerable: no mitochondria → PPP is the only NADPH source
Without NADPH → cannot regenerate GSH → oxidative damage → Heinz bodies → hemolytic anemia
Triggers: primaquine, dapsone, nitrofurantoin, fava beans, infections
Heterozygote advantage: protection against malaria

What the cell does based on its needs:

Need	Action
NADPH only	Oxidative phase runs; ribulose 5-P recycled back → glucose 6-P
Ribose 5-P only	Non-oxidative reactions from glycolytic intermediates (no oxidative phase needed)
Both equally	Oxidative phase; ribose 5-P retained
Neither	G6PD inhibited by high NADPH

PYRUVATE METABOLISM

Where pyruvate comes from

Pyruvate is the end product of glycolysis (from glucose, lactate, alanine). It sits at a metabolic crossroads with 5 possible fates:

Fate	Enzyme	Condition	Product
1. → Acetyl CoA	Pyruvate dehydrogenase complex (PDC)	Aerobic, fed	Enters TCA cycle
2. → Lactate	Lactate dehydrogenase (LDH)	Anaerobic, RBCs	Regenerates NAD⁺
3. → Oxaloacetate (OAA)	Pyruvate carboxylase	Fasting (gluconeogenesis)	OAA → glucose
4. → Alanine	Alanine aminotransferase (ALT)	Muscle (glucose-alanine cycle)	Nitrogen transport
5. → Ethanol	Pyruvate decarboxylase	Yeast only	Not in humans

Pyruvate Dehydrogenase Complex (PDC)

Reaction: Pyruvate + CoA + NAD⁺ → Acetyl CoA + CO₂ + NADH

Location: Mitochondrial matrix
Irreversible reaction (links glycolysis to TCA cycle)

Pyruvate Dehydrogenase Complex reaction showing pyruvate converted to Acetyl CoA with cofactors TPP, lipoate, FAD, NAD+, CoASH

Three enzyme subunits and their cofactors (mnemonic: "Tender Loving Care For Nick"):

Enzyme	Subunit	Cofactor/Vitamin
E1 - Pyruvate decarboxylase	Decarboxylates pyruvate	TPP (Thiamine B1)
E2 - Dihydrolipoyl transacetylase	Transfers acetyl group	Lipoic acid + CoA (Pantothenate B5)
E3 - Dihydrolipoyl dehydrogenase	Reoxidizes lipoate	FAD (Riboflavin B2) + NAD⁺ (Niacin B3)

Cofactors to remember: TPP, Lipoic acid, FAD, NAD⁺, CoA (mnemonic: "The Lovely Fairy Needs Candy")

Regulation of PDC

PDC regulation diagram showing PDC kinase inactivating and PDC phosphatase activating the complex

PDC is active when dephosphorylated, inactive when phosphorylated.

Activates PDC	Inactivates PDC
Insulin	High Acetyl CoA
ADP (low energy)	High NADH
Pyruvate (substrate)	High ATP
Ca²⁺ (activates phosphatase)	High Fatty acid oxidation
NAD⁺, CoA

PDC Kinase → phosphorylates → INACTIVE (stimulated by Acetyl CoA, NADH, ATP)
PDC Phosphatase → dephosphorylates → ACTIVE (stimulated by Ca²⁺, insulin)

PDC Deficiency (Clinical)

Lactic acidosis at birth (pyruvate cannot enter TCA → builds up → lactate)
Leigh syndrome (subacute necrotizing encephalopathy)
Brain most affected: depends entirely on glucose oxidation for energy
Gene: E1-α subunit, X-linked dominant
Treatment: Ketogenic diet (bypasses need for PDC; ketones used by brain)

Thiamine Deficiency - Practical Impact

Both PDC and transketolase (PPP) require Thiamine (B1). Deficiency causes:

Beriberi - cardiac/neurological
Wernicke-Korsakoff syndrome - in alcoholics
Raised blood lactate (PDC blocked → pyruvate → lactate)
Transketolase activity in RBCs is used as a clinical test for thiamine status

Connection Between Both Pathways

Glucose
   ↓ Glycolysis
Glucose 6-Phosphate ─────────────→ PENTOSE PHOSPHATE PATHWAY
   ↓ Glycolysis continues              (NADPH + Ribose 5-P)
Pyruvate
   ↓ PDC (mitochondria)
Acetyl CoA → TCA Cycle → ATP

Both pathways branch from glucose 6-phosphate in the cytosol. The cell decides which route based on its immediate needs - energy (glycolysis/TCA) vs. biosynthesis/redox protection (PPP).

(Sources: Lippincott Biochemistry 8e, Chs 13 & 9; Basic Medical Biochemistry 6e, Chs 23 & 27; Harper's Illustrated Biochemistry 32e)

Pentose phosphate pathways

Here are complete, exam-ready notes on the Pentose Phosphate Pathway — all sourced from the previous textbook search which is still in context.

PENTOSE PHOSPHATE PATHWAY (HMP Shunt)

Complete Exam Notes

Basic Facts

Feature	Detail
Other names	HMP Shunt, Phosphogluconate pathway, Warburg-Dickens pathway
Location	Cytosol
Substrate	Glucose 6-phosphate
ATP produced	None
Key products	2 NADPH + Ribose 5-phosphate + CO₂
Linked pathway	Branches off from glycolysis at G6P

Overview Diagram

Complete pentose phosphate pathway showing oxidative (irreversible) and nonoxidative (reversible) phases

PHASE 1 - Oxidative Phase (IRREVERSIBLE)

Step-by-step oxidative reactions from Glucose 6-phosphate to Ribulose 5-phosphate

3 irreversible steps generating 2 NADPH:

Step 1 - Rate-Limiting Step

Enzyme: Glucose 6-phosphate dehydrogenase (G6PD)

Glucose 6-P + NADP⁺ → 6-phosphoglucono-δ-lactone + NADPH
This is the committed step and rate-limiting step of the entire pathway
Inhibited by NADPH (product inhibition)
Induced by insulin

Step 2

Enzyme: 6-Phosphogluconolactonase (Gluconolactonase)

6-Phosphoglucono-δ-lactone + H₂O → 6-Phosphogluconate
Simple hydrolysis, no redox change

Step 3

Enzyme: 6-Phosphogluconate dehydrogenase

6-Phosphogluconate + NADP⁺ → Ribulose 5-phosphate + NADPH + CO₂
Oxidative decarboxylation - loses C1 as CO₂
Mechanistically similar to isocitrate dehydrogenase in TCA cycle

Summary of Phase 1:

Glucose 6-P → Ribulose 5-P + 2 NADPH + CO₂

PHASE 2 - Non-Oxidative Phase (REVERSIBLE)

Ribulose 5-P is the starting point. Three fates:

1. → Ribose 5-phosphate (via ribose 5-P isomerase)

Used for nucleotide and nucleic acid synthesis (ATP, NADH, RNA, DNA)

2. → Xylulose 5-phosphate (via phosphopentose epimerase)

Used as donor in transketolase reactions

3. → Fructose 6-P + Glyceraldehyde 3-P (re-enters glycolysis)

Via Transketolase + Transaldolase reactions

Key Non-Oxidative Enzymes

Enzyme	Cofactor	Carbon transfer	Action
Transketolase	TPP (Thiamine B1)	Transfers 2C units	5C+5C → 7C+3C then 7C+5C → 4C+6C
Transaldolase	None	Transfers 3C units	7C+3C → 4C+6C

Net equation for non-oxidative phase recycling:

3 Ribulose 5-P → 2 Fructose 6-P + 1 Glyceraldehyde 3-P (These then re-enter glycolysis or gluconeogenesis)

What Does the Cell Do Based on Its Needs?

Cellular Need	Pathway Direction
NADPH only (e.g. RBCs)	Oxidative phase runs repeatedly; ribulose 5-P → recycled back to glucose 6-P via non-oxidative reactions
Ribose 5-P only (e.g. rapidly dividing cells)	Non-oxidative reactions run in reverse from fructose 6-P + G3P (no NADPH made)
Both NADPH + Ribose 5-P	Oxidative phase only; ribose 5-P is kept
Both + pyruvate (energy)	Both phases; products flow into glycolysis → pyruvate

Active Tissues & Why

Tissue	Active Because...
Liver	Fatty acid synthesis, cholesterol synthesis
Adipose tissue	Fatty acid synthesis
Lactating mammary gland	Fatty acid synthesis for milk
Adrenal cortex	Steroid hormone (cortisol, aldosterone) synthesis
Gonads (testis, ovary)	Sex steroid synthesis
Red blood cells	NADPH → GSH regeneration (oxidant protection) - most important clinically
Phagocytes (neutrophils)	NADPH oxidase → O₂⁻ for killing bacteria
Low in: skeletal muscle	Muscle has very low G6PD activity

NADPH - All Functions

                    NADPH
                      │
     ┌────────────────┼────────────────────┐
     ↓                ↓                    ↓
Fatty acid      Steroid synthesis    Glutathione
synthesis       (adrenal, gonads)    reduction (GSH)
                                         │
                                   ↓ in RBCs
                              Protects against
                              oxidative damage
                                    +
                            Cytochrome P450
                            (drug detox in liver)
                                    +
                            NADPH oxidase
                            (respiratory burst)

Regulation

G6PD is the key regulatory enzyme:

Inhibited by: NADPH (when the cell has enough, pathway slows down)
Activated by: High NADP⁺:NADPH ratio (when cell needs more NADPH)
Induced by: Insulin (in fed/absorptive state - upregulates G6PD gene expression)
Not regulated by: AMP, ADP, or ATP (unlike glycolysis)

G6PD Deficiency - Clinical Details

Feature	Detail
Inheritance	X-linked recessive
Sex affected	Mostly males (females are carriers)
Prevalence	Most common enzyme deficiency worldwide
Mechanism	↓ NADPH → cannot regenerate GSH → oxidative damage → Heinz bodies → hemolytic anemia
Why RBCs?	No mitochondria → PPP is the only NADPH source in RBCs
Triggers	Primaquine, dapsone, nitrofurantoin, fava beans (favism), infections
Lab finding	Heinz bodies on peripheral smear, bite cells
Evolutionary advantage	Heterozygous females are protected against Plasmodium falciparum malaria

Thiamine Deficiency and the PPP

Transketolase requires TPP (Thiamine/Vitamin B1)

Thiamine deficiency → transketolase activity falls → non-oxidative phase blocked
Clinical test: Measure RBC transketolase activity with and without added TPP
- If activity jumps with added TPP → thiamine deficient
Diseases: Beriberi, Wernicke-Korsakoff syndrome (alcoholics)

Connecting PPP to Other Pathways

Glucose
    ↓ (Hexokinase)
Glucose 6-Phosphate ──────────────────────────────────┐
    ↓ (Phosphoglucose isomerase)                       │
Fructose 6-P → GLYCOLYSIS → Pyruvate                  │
                                                   PPP (HMP Shunt)
                                                       │
                                               2 NADPH + Ribose 5-P
                                                       │
                                        ┌──────────────┴────────────┐
                                    Nucleotide               Back to
                                    biosynthesis          Fructose 6-P
                                    (RNA, DNA, ATP)        (glycolysis)

High-Yield Exam Points

Rate-limiting enzyme = G6PD (not glucose 6-phosphatase - that's gluconeogenesis)
Generates NADPH, NOT NADH - completely different coenzyme
First step = oxidation of G6P to 6-phosphoglucono-δ-lactone (not to 6-phosphogluconate directly)
Transketolase needs Thiamine (B1) - clinically testable
RBCs rely entirely on PPP for NADPH - no mitochondria
Insulin activates the pathway (via G6PD induction)
PPP is active in tissues doing biosynthesis (liver, fat, adrenal), not energy-demanding ones (muscle, heart)
3 glucose 6-P → 6 CO₂ + 12 NADPH (if fully oxidized cyclically)
The pathway produces both pentoses (5C) and hexoses (6C) and trioses (3C) in the non-oxidative phase
G6PD deficiency = favism when fava beans are eaten

(Sources: Lippincott Biochemistry 8e Ch. 13; Basic Medical Biochemistry 6e Ch. 27; Harper's Illustrated Biochemistry 32e Ch. 15)

This is a shared conversation. Sign in to Orris to start your own chat.